彩色眼底成像、荧光素眼底血管造影与谱域光学相干断层扫描在新生血管性年龄相关性黄斑变性黄斑纤维化检测中的一致性
本研究为临床队列与诊断准确性研究,对130只新生血管性年龄相关性黄斑变性眼在启动抗血管内皮生长因子(anti-VEGF)治疗18个月后采集的多模态眼底图像重新分级纤维化与高反射物质(HRM)。以彩色成像为参照,FA的kappa为0.56,SD-OCT上HRM的kappa为0.40;SD-OCT检出的HRM可解释最佳矫正视力(BCVA)变异,提示OCT是检测纤维化的更优标准。
要点
- 以彩色成像为参照,FA检测纤维化的kappa为0.56,SD-OCT检测HRM的kappa为0.40。
- 各检测与BCVA回归的R²均<0.09;HRM-OCT模型纳入位置与尺寸后R²升至0.301。
- 以SD-OCT的HRM为参照,彩色与FA联合的敏感度为87.5%,仅SPE时为33.3%。
核心结论
- SD-OCT在抗VEGF治疗维持期检出的边界清晰的HRM可解释BCVA变异,OCT是检测纤维化的更优标准。
研究设计与样本
- 临床队列与诊断准确性研究,纳入新生血管性年龄相关性黄斑变性130只眼,图像采集于启动anti-VEGF治疗18个月后,属Early Detection of Neovascular AMD(EDNA)研究的一部分。
- 对彩色、FA与SD-OCT多模态眼底图像重新分级纤维化与HRM,HRM位置分为视网膜下(SR)和(或)视网膜色素上皮下(SPE)。
- 一致性用kappa统计量评估,并以BCVA为结局变量做回归分析评估临床相关性。
主要发现
- 以彩色成像为参照,FA的kappa为0.56,SD-OCT上HRM的kappa为0.40。
- 各检测对BCVA回归的R²均较低(R²<0.09)。
- HRM-OCT模型以无HRM为参照、位置与尺寸为协变量时,R²增至0.301。
- SR的字母丢失为21.1(P<.0001),SPE的字母丢失为8.1(P=.045)。
- 以SD-OCT的HRM为参照,彩色与FA联合的敏感度为87.5%,仅SPE时敏感度较低,为33.3%。
关键数值与推荐
- 以彩色成像为参照,FA检测纤维化的kappa为0.56。
- 以彩色成像为参照,SD-OCT检测HRM的kappa为0.40。
- SR的字母丢失为21.1(P<.0001),SPE的字母丢失为8.1(P=.045)。
- 以SD-OCT的HRM为参照,彩色与FA联合的敏感度为87.5%,仅SPE时为33.3%。
临床怎么用
- 原文结论认为,抗VEGF治疗维持期SD-OCT检出的边界清晰HRM可解释BCVA变异,OCT是检测纤维化的更优标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the agreement between fibrosis on color imaging-, fluorescein angiography (FA)-, and spectral domain optical coherence tomography (SD-OCT)-detected hyperreflective material (HRM) and assess their clinical relevance. DESIGN: Clinical cohort and diagnostic accuracy study. METHODS: Multimodal fundus images (color, FA, and SD-OCT) of 130 eyes with neovascular age-related macular degeneration, collected 18 months after the initiation of anti-vascular endothelial growth factor treatment (anti-VEGF) as part of the Early Detection of Neovascular AMD (EDNA) study, were regraded for fibrosis and HRM. HRM location was assigned as subretinal (SR) and/or subretinal pigment epithelial (SPE). Agreement between detection methods was assessed with the kappa statistic, and regression analysis with best corrected visual acuity (BCVA) as outcome variable was used to evaluate clinical relevance. RESULTS: Kappa was 0.56 for FA and 0.40 for HRM on SD-OCT, using color as the reference. Regression against BCVA showed low R² values for all tests (R² < 0.09). In the HRM-OCT model, with no HRM as the reference and location and dimensions as covariates, the R² increased to 0.301. Letter loss was 21.1 (P < .0001) for SR and 8.1 (P = .045) for SPE. When HRM on SD-OCT was the reference, the sensitivity for color and FA combination was 87.5% but was lower at 33.3% for SPE only. CONCLUSIONS: Well-defined HRM detected by SD-OCT during the maintenance phase of anti-VEGF therapy explains BCVA variance, positioning OCT as a superior standard for detecting fibrosis.
引用
- Csincsik L, Cheung CMG, Bannon F, et al. Agreement Between Color, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography in the Detection of Macular Fibrosis in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2025. PMID: 39880106. doi:10.1016/j.ajo.2025.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。